Position in CYTK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,310,437
+$479,655 QoQ
Shares Held
27,121
-2.4% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#208
of 473 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,287,535 across 174 Biotechnology names. CYTK ranks #6 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
This page
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,310,437 | 27,121 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,830,782 | 27,777 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,047,195 | 32,219 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,611,976 | 29,330 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,113,778 | 33,710 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,411,271 | 35,115 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,036,784 | 43,299 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,778,251 | 33,679 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,439,400 | 26,567 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,044,898 | 29,167 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,991,570 | 23,854 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $604,283 | 20,512 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $678,463 | 20,799 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $661,783 | 18,806 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $969,047 | 21,149 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $946,422 | 19,534 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $720,657 | 18,342 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $978,188 | 26,574 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,447,711 | 31,762 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,077,954 | 30,161 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $643,333 | 32,508 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $690,659 | 29,693 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $560,602 | 26,978 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $449,583 | 20,766 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $426,781 | 18,107 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $145,606 | 12,350 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||